Clinical Trial Update: Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine

View source ↗

Summary

Clinical trial update noting a potential association between exposure to pravastatin and paroxetine and the development of Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postpartum Depression
• Type 2 Diabetes Mellitus

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• Pravastatin (pravastatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depression, Postpartum | Status: COMPLETED